Atlas Trials

MRI Screening for Brain Metastases Among Patients With Triple Negative or HER2+ Stage II or III Breast Cancer

Clinical trial NCT06247449 · RECRUITING

Trial details

NCT number
NCT06247449
Sponsor
Sunnybrook Health Sciences Centre
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Breast Cancer
Start date
2023-11-29
Primary completion
2027-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.